Maryannick Lamorlette

Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers

Bernard Barlaam, Sabina Cosulich, Bénédicte Delouvrié et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 35 citations

Medicine, Medicinal Chemistry, Pharmacology +8

An efficient large-scale synthesis of alkyl 5-hydroxy-pyridin- and pyrimidin-2-yl acetate

Rémy Morgentin, Frédéric Jung, Maryannick Lamorlette et al. · Tetrahedron · 2008 · 22 citations

Natural Sciences, Chemistry, Medicinal Chemistry +3

Strategic studies in the syntheses of novel 6,7-substituted quinolones and 7- or 6-substituted 1,6- and 1,7-naphthyridones

Rémy Morgentin, Georges Pasquet, Pascal Boutron et al. · Tetrahedron · 2008 · 22 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

A versatile route to 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridines and 3-(pyrimidin-4-yl)-pyrazolo[1,5-a]pyridines

Richard Ducray, Pascal Boutron, Myriam Didelot et al. · Tetrahedron Letters · 2010 · 19 citations

Pharmacy, Chemistry, Medicinal Chemistry +8

Conformational analysis of 5-lipoxygenase inhibitors: role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series

Christine Lambert‐van der Brempt, Pierre Bruneau, Maryannick Lamorlette et al. · Journal of Medicinal Chemistry · 1994 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14